Merck On A Mission To Introduce Automation To Fertility Treatment
Executive Summary
Healthcare giant Merck is on a mission to introduce automation to fertility treatment and improve patient outcomes. The German company, already a leader in fertility drugs, aims to expand its market position by delivering innovative device technologies.
You may also be interested in...
Testing For Toxicity In Fertility Treatment Technologies
US regulators are proposing makers of fertility assistant devices first test their products on mice embryos in the lab to better understand any potential toxicity risk to human embryos and the viability of the fetus.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.